FIELD: medicine, oncology, immunology, endocrinology, pharmacy.
SUBSTANCE: invention proposes a pharmaceutical composition that comprises GnRH or its peptide analogue optionally bound with a protein-carrier enhancing the immune response, and growth-regulating factor chosen from EGF and VEGF optionally bound with protein. Synergistic effect revealed between growth-regulating factors EGF, TGF and VEGF and hormones results to stimulation of the antitumor response that is expressed as decreasing tumor mass and increasing the span-life period.
EFFECT: valuable medicinal properties of combinations.
7 cl, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION WITH USING COMBINED VARIANTS OF GONADOTROPIN RELEASING HORMONE (GnRH) AS IMMUNOGEN | 2009 |
|
RU2537138C2 |
| RECOMBINANT PROTEINS AND THEIR THERAPEUTIC USES | 2012 |
|
RU2650574C2 |
| RECOMBINANT PROTEINS AND THEIR APPLICATIONS IN THERAPEUTIC PURPOSES | 2018 |
|
RU2766595C2 |
| NEW SYNERGETIC EFFECTS | 2009 |
|
RU2471499C2 |
| COMBINED THERAPY USING INHIBITORS OF TYROSINE KINASE RECEPTORS AND INHIBITORS OF ANGIOGENESIS | 2001 |
|
RU2292904C2 |
| SELF-ASSEMBLY SYNTHETIC PROTEINS | 2014 |
|
RU2801230C2 |
| COMBINED THERAPY BY USING ANTIANGIOGENIC AGENTS AND TNF-ALPHA | 2002 |
|
RU2316337C2 |
| PHARMACEUTICAL COMPOSITIONS AIMED AT Erb-B1 RECEPTORS | 2003 |
|
RU2354402C2 |
| METHODS FOR TREATMENT OF TUMORS AND METASTASIS USING COMBINATION OF ANTI-ANGIOGENIC THERAPY AND IMMUNOTHERAPY | 2000 |
|
RU2236251C2 |
| METHOD FOR PREVENTING BENIGN PROSTATE HYPERPLASIA IN MALE PATIENTS DISTINGUISHED BY PARTIAL ANDROGEN AGE-SPECIFIC DEFICIENCY (PADAM) | 2002 |
|
RU2236175C2 |
